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Background: Feline immunodeficiency virus (FIV) is a widespread pathogen of the domestic cat and an important
animal model for human immunodeficiency virus (HIV) research. In contrast to HIV, only limited information is
available on the transcriptional host cell response to FIV infections. This study aims to identify FIV-induced gene
expression changes in feline T-cells during the early phase of the infection. Illumina RNA-sequencing (RNA-seq) was
used identify differentially expressed genes (DEGs) at 24 h after FIV infection.
Results: After removal of low-quality reads, the remaining sequencing data were mapped against the cat genome
and the numbers of mapping reads were counted for each gene. Regulated genes were identified through the
comparison of FIV and mock-infected data sets. After statistical analysis and the removal of genes with insufficient
coverage, we detected a total of 69 significantly DEGs (44 up- and 25 down-regulated genes) upon FIV infection.
The results obtained by RNA-seq were validated by reverse transcription qPCR analysis for 10 genes.
Discussion and conclusion: Out of the most distinct DEGs identified in this study, several genes are already
known to interact with HIV in humans, indicating comparable effects of both viruses on the host cell gene
expression and furthermore, highlighting the importance of FIV as a model system for HIV. In addition, a set of new
genes not previously linked to virus infections could be identified. The provided list of virus-induced genes may
represent useful information for future studies focusing on the molecular mechanisms of virus-host interactions in
FIV pathogenesis.
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Feline immunodeficiency virus (FIV) was first isolated
from domestic cats in 1986 and has since then become an
important animal model for human immunodeficiency
virus (HIV) research [1,2]. Both viruses belong to the
genus of lentiviruses and can be transmitted pre- and
postnatally, via blood transfer and mucosal contact [2,3].
FIV can infect a broad range of cell types, including
T-cells, B-cells, macrophages, and cells of the central ner-
vous system. The genomes of FIV and HIV share the three
main structural genes: gag, pol and env, as well as the two
accessory genes: rev and vif. However, HIV encodes four
additional accessory genes not present in FIV: vpr, vpu, tat
and nef. In contrast, the orf-A gene can be found uniquely
in FIV. Despite these differences on the genome level, FIV* Correspondence: reinhard.ertl@vetmeduni.ac.at
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unless otherwise stated.induced pathogeneses display striking similarities to hu-
man AIDS [2]. FIV progresses through three clinical
stages, finally leading to an acquired immunodeficiency
syndrome that increases the incidence of opportunistic in-
fections and secondary diseases [4]. After the infection of
a target cell, lentiviruses parasitize the cellular machinery
to complete their life cycles. Following virus entry into the
cell, the viral RNA genome is reverse transcribed and sub-
sequently integrated into the cellular genome. The host
cell machinery is then used to generate viral transcripts.
These transcripts will be partially spliced and used as tem-
plates for the translation of the respective viral proteins.
On the contrary, unspliced transcripts are incorporated
into new virus particles, assembled from the structural
viral proteins [5]. During all these steps, viral factors inter-
act with multiple cellular proteins and hence, affect the
normal course of cellular processes. These virus-induced
changes of physiological processes can be detected on
transcriptional and protein levels. For HIV, multiplel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Quantification of FIV provirus DNA in infected T-cells.
Numbers of FIV DNA copies per cell at 8 and 24 hpi were determined
by qPCR.
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at several stages of infection [6]. Some of these genes dir-
ectly interact with viral proteins, whereas others might be
only side-effects of the virus-induced changes in the host
cell environment. Currently, only limited data is available
about the impact of FIV infection on the host cell tran-
scription. However, previous studies using cDNA microar-
rays suggest that transcriptional changes induced by FIV
differ in between different cell types [7]. Furthermore, mi-
croarrays have been used to analyze the consequences of
the viral Orf-A expression on the cellular mRNA profile
[8]. In the present study, we use for the first time next-
generation RNA sequencing (RNA-seq) to investigate the
transcriptional host cell response to FIV [9]. T-cells were
infected with FIV and the virus induced gene expression
changes were investigated at 24 h post infection (hpi). The
most significantly affected genes were additionally investi-
gated by reverse transcriptase qPCR (RT-qPCR) at 8 and
24 hpi [10]. The results of this study will contribute gaining
deeper insights into the complex network of virus-host in-
teractions in FIV pathogenesis.
Results
Infection of T-cells and transcriptome sequencing
FeT-J cells, a feline T-lymphocyte cell line, were infected
with the FIV Petaluma strain. A high multiplicity of in-
fection (MOI) of 10 virions per cell was used in order to
ensure infection of the majority of target cells. FIV- and
mock-infected cells were harvested at 8 and 24 hpi.
Four replicates were analyzed for each time-point. The
amounts of FIV provirus DNA were determined by quan-
titative PCR (qPCR) to estimate the infection efficiencies.
At both time points similar provirus loads (7 FIV copies
per cell) were detected, indicating successful infection of
all replicate samples (Figure 1). The small decrease ob-
served from 8 to 24 hpi can be explained by continuous
cell division, while the production of new virus particles
is expected to take a minimum of 24 h. High quality total
RNAs (RNA integrity numbers of 10) of FIV (24 hpi) and
mock infected cells were used for poly-A mRNA purifica-
tion and the subsequent preparation of cDNA libraries
for transcriptome sequencing. Next generation sequen-
cing analysis on an Illumina platform generated a total of
42–57 million 37-bp reads per replicate sample (Table 1).
Out of these, 40–56 million reads passed the quality
filtering and were mapped against the cat reference
genome. 60% of the filtered reads could be mapped to
the cat genome. Additionally, in FIV infected cells 0.2%
of reads were assigned to the FIV Petaluma genome sug-
gesting the beginning of viral RNA transcription.
Identification of differentially expressed genes
For quantification of transcript numbers, the filtered se-
quencing reads were assigned to the annotated genespresent on the current version of the cat genome. Num-
bers of reads mapping to particular genes were counted
and normalized by converting them into RPKM-values
(reads per kilobase per million mapped reads) [11]. Out
of 19,947 annotated genes present on the reference gen-
ome, sample reads could be assigned to 17,998 genes,
leaving 1,949 genes without any mapping reads. For dif-
ferential expression analysis, fold-changes and p-values
were calculated in between the mean read counts of
FIV-and mock-infected cells. The p-values were adjusted
for multiple testing, according to the procedure pro-
posed by Benjamini and Hochberg [12]. This statistical
procedure was implemented to account for the multiple
comparison problem that occurs during the analysis of
high-throughput data. High numbers of hypotheses (e.g.
differential expression of multiple genes) that are tested
in one data set increase the probability that one of them
is incorrectly accepted by chance. Correction methods,
like Benjamin-Hochberg, are frequently used for large
genomic data and call for adjustments, so that the prob-
ability of finding at least one significant result due to
chance remains below the implemented significance level
[12,13]. In order to ensure sufficient coverage of all ana-
lyzed genes, the threshold for transcription was set to a
minimum RPKM-value of 0.5 in all replicate samples.
Thus, genes with RPKM < 0.5 were excluded from the
analysis. Genes exhibiting fold changes > 2 and adjusted
p-values < 0.05 were considered as differentially expressed.
This analysis strategy resulted in a total number of 69
differentially expressed genes (DEGs) at 24 h after FIV
infection. The complete list of DEGs can be found in
Additional file 1: Table S1. Out of these genes, 44 were
up- and 25 down-regulated. The observed fold changes
range from 2- to 5-fold, with the majority of genes be-
ing moderately (2- to 3-fold) up-regulated. Out of the
Table 1 Numbers of Illumina sequencing reads per replicate sample
Sample Description Numbers of reads
Raw Filtered Mapping cat genome Mapping FIV genome
1 Mock 46,309,391 45,147,168 27,254,153 0
2 Mock 53,685,029 52,542,136 31,599,152 0
3 Mock 57,062,177 56,196,638 34,375,083 0
4 Mock 52,365,374 51,444,090 31,300,419 0
5 FIV 24 hpi 42,631,408 40,486,522 24,221,149 78,104
6 FIV 24 hpi 43,382,804 42,296,304 24,862,708 108,985
7 FIV 24 hpi 46,555,404 45,552,109 27,350,225 85,229
8 FIV 24 hpi 48,539,624 47,351,395 27,513,918 133,436
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down- and 17 were up-regulated (Table 2).
Validation of differential expressions by RT-qPCR
RT-qPCR was performed in order to verify the results
from transcriptome sequencing for 10 DEGs. The 10
genes were selected out of the 20 most significantly
DEGs detected by RNA-seq (Table 2). Expression changes
compared to mock-infected cells were additionally ana-





Log2 read counts Adjusted
p-value
Validation
by RT-qPCRMock FIV 24 hpi
OASL 3.438 8.558 10.340 2.82E-07 Yes
ACHE 2.618 8.011 9.400 2.16E-06 Yes
DHX58 2.578 11.431 12.797 4.98E-06 No
DDX58 2.842 7.276 8.783 6.51E-06 No
TGM2 5.425 4.792 7.231 8.45E-06 Yes
HMGN2 −2.061 12.013 10.969 9.68E-05 Yes
CDKN1A 2.083 9.092 10.152 1.40E-04 Yes
ZFP36 2.040 7.806 8.834 2.98E-04 Yes
BCL6 2.102 3.744 4.817 3.32E-04 Yes
ASB2 5.465 3.050 5.500 3.72E-04 No
CSF1 2.042 7.056 8.087 3.91E-04 Yes
FITM1 2.082 2.227 3.286 4.69E-04 No
IFI44 2.587 4.470 5.841 1.75E-03 Yes
TP53INP1 2.226 4.988 6.143 1.77E-03 No
BMF 2.281 3.717 4.907 1.85E-03 No
SPINK4 −2.896 3.157 1.623 2.28E-03 No
HSPE1 2.985 3.005 4.583 3.20E-03 No
COA1 −2.516 3.559 2.227 3.54E-03 No
CXCL11 3.130 0.750 2.396 4.16E-03 Yes
ERBB2 2.312 1.123 2.333 5.42E-03 No
Most significantly regulated genes in FIV infected cells at 24 hpi as detected by
RNA-seq. Fold changes were obtained by comparison of the mean read counts
of FIV vs. mock infected cells. Genes were ranked according to the p-values.expression changes determined by RNA-seq could be con-
firmed by RT-qPCR for all investigated genes at 24 hpi
(Figure 2). The highest virus induced changes were de-
tected for TGM2 and OASL, analogue to the sequencing
results. Compared to 24 hpi, the observed expression
changes were generally lower at 8 hpi.
Discussion
Since viruses have only a few genes, the use of the cellu-
lar machinery for the generation of viral transcripts and
proteins is essential for their replication. Thus, virus rep-
lication interferes with normal cellular processes and
therefore affects the expression of cellular genes. At
present, only limited information is available on the
effect of FIV infections on the host cell transcription.
Here, we perform transcriptome analysis to investi-
gate FIV induced gene expression changes in infected
T-cells. A total of 69 DEGs could be identified at 24 hpi
(Additional file 1: Table S1). As the validity of transcrip-
tome data is dependent on sufficient numbers of sequen-
cing reads mapping to all individual genes [14], we
considered only genes with a minimum coverage (RPKM
values > 0.5) for differential expression analysis. Due to
this stringent threshold level, some lowly expressed genes
were removed from the analysis. However, this approach
could improve the reliability of the final list of DEGs.
Furthermore, the expression patterns of 10 genes were
confirmed by RT-qPCR (Figure 2), confirming that RNA-
seq is a suitable method for the quantification of RNA
expression levels. The comparison of RT-qPCR results
for two time points (8 and 24 hpi) revealed generally
lower expression changes for the 10 investigated genes at
8 hpi, thus indicating time-dependent induction of par-
ticular genes during the initial phase of infection. So far,
only limited information is available about transcriptional
changes modulated by FIV. However, previous studies in-
vestigated the impact of the viral orf-A gene on the host
cell transcription. Here, alterations in several genes, re-
sponsible for post-transcriptional RNA modification and
protein ubiquitination, were identified in T-cells expressing
Figure 2 Validation of 10 selected DEGs by RT-qPCR and comparison with RNA-sequencing. RT-qPCR gene expression levels at 8 and 24 hpi
were compared to mock infected cells. Fold changes were obtained by merging the mean values of 4 replicates for each time point, previously
normalized to the expression of the 3 reference genes ABL, B2M and RSP7. Stars indicate significant (p < 0.05) expression changes.
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contrast to that, we could not detect changes for these
genes in our data. We assume that these discrepancies can
be mainly attributed to different experimental setups, espe-
cially regarding the exposure time to the stimulus, as we
investigated the early antiviral response whereas the previ-
ous study used stable Orf-A expressing cell lines [8]. More-
over, these results may also indicate differences in the
cellular responses to individual viral proteins compared to
complete viruses.
FIV induced gene expression changes: Similarities to HIV
Out of the 69 FIV induced genes (Additional file 1:
Table S1); several genes have already been described
to be affected also by infection with other viruses, in
particular HIV. OASL, the most significantly regulated
gene upon FIV infection (up-regulated 3.4-fold; Table 2)
is known as an antiviral protein, induced by a variety of
viruses, such as the influenza A and hepatitis C virus
[15,16]. Other examples include DHX58 and DDX58
(up 2.6- and 2.8-folds), belonging to the group of RNA
helicases. These enzymes are involved in many processes
of the cellular RNA metabolism including the sensing of
viral RNAs and the mediation of antiviral immune re-
sponses [17]. ACHE (up 2.6-fold) encodes for an enzyme
necessary for the termination of neuro-transmitted sig-
nals. Furthermore, the plasma secretion of this protein is
accomplished via exosome-like vesicles that are also used
by HIV for the release of viral Nef proteins. Thus, HIV
increases ACHE expression and vesicle production in
order to enhance the export of its own proteins [18]. We
detected TGM2 to be highly up-regulated (up 5.4-fold)
after FIV infection, similar to previous findings for HIV
[19]. This multifunctional protein is involved in several
cellular processes including apoptosis. The induction of
TGM2 might be an antiviral mechanism of the host cells
in order to trigger apoptosis and interfere with virus rep-
lication [20]. HMGN2 (down 2.1-fold) is presumed to beinvolved in HIV replication due to interactions with the
viral integrase [21]. CDKN1A (other names: p21/waf1;
up 2.1-fold) encodes a cyclin-dependent kinase inhibitor
that functions as a regulator of cell cycle progression, es-
pecially in the promotion of cell cycle arrest. HIV affects
the function of the encoded protein and thus, influences
cell cycle progression [22]. The induction of cell cycle ar-
rest might benefit viruses because of the resulting sup-
pression of immune responses and the generation of an
optimized cellular environment for viral reproduction
[23]. In contrast, the increase of ZFP36 (tristetraprolin;
up 2.0-fold) might be an antiviral response of the host
cell. ZFP36, due to its zinc finger motifs, is able to inter-
act with specific AU-rich regions of HIV RNAs and
consequently targets them for rapid degradation [24].
Together with other cellular defense mechanisms, this
process may represent an additional antiviral barrier that
aims to block virus replication at the transcription level.
Similar functions, as a transcriptional repressor of HIV
have also been described for BCL6 (up 2.1-fold) [25].
Other examples of genes affected by FIV that have previ-
ously been associated with HIV pathogenesis include
CSF1, IFI44, HSPE1 and CXCL11. The protein encoded
by CSF1 (up 2.0-fold) is a secreted cytokine that controls
the production, differentiation and function of macro-
phages. The induction of this pro-survival cytokine by
HIV facilitates protection infected cells from apoptosis
[26]. IFI44 (MTAp44; up 2.6-fold) is inducible by inter-
ferons (IFNs) which are released by cells in response to
the presence of viruses, bacteria and parasites. IFNs trig-
ger the early antiviral defense of the immune system that
aims to eradicate the pathogens. IFI44 is frequently up-
regulated in virus infected cells generating an antiprolif-
erative state, impeding viral replication [27,28]. HSPE1
(up 3.0-fold) encodes a major heat shock protein. These
stress proteins are expressed in response to a broad range
of stimuli such as heat and microbial infections. Add-
itionally, interactions with HIV suggest functions in the
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Another IFN induced gene is CXCL11 (up 3.1-fold)
which functions as a chemokine and is the dominant
ligand for the CXC receptor-3 on immune cells. Its
release initiates a chemotactic response in activated
T-cells recruiting them to lymphoid organs. In the case
of lentiviral infections, the migration of additional cells
to infected lymph nodes increases the numbers of po-
tential target cells and thus, contributes to the spread
of infection [30].
Several of the DEGs identified in this study are known to
interact with HIV accessory proteins that are missing in
FIV. The HIV Tat protein functions as an activator of viral
RNA transcription and is responsible for the induction of
several cellular genes, such as CDKN1A [31], BCL6 [32],
IFI44 [27], C1QTNF5, EEFCC1 [33] and COX4I1 [34]. For
CDKN1A, additional interactions have been described with
HIV Vpr [35]. As we observed expression changes for all
these genes also in this study, similar mechanisms can be
assumed for FIV. Here, other viral genes might adopt the
particular functions attributed to HIV Tat and Vpr.
Conclusion
Taken together, we investigated the virus induced gene
expression changes in FIV infected T-cells. Using next-
generation sequencing technology, a total of 69 DEGs were
identified at 24 hpi. Out of those genes most significantly
affected by FIV, several genes could be associated to known
interactions with HIV in humans. These findings indicate a
similar effect of both viruses on the host cell transcription
and further underline the importance of FIV as a model
system for HIV research. The virus-induced genes identi-
fied in this study represent potential cellular factors in-
volved in FIV pathogenesis and may serve as a basis for
future investigations aiming to provide new insights into
the molecular mechanisms of lentiviral infections.
Materials and methods
Cells and viruses
FeT-J cells were purchased from ATCC (CRL-11967).
Cells were cultivated in RPMI 1640 medium supplemented
with 10% FBS, 1 mM sodium pyruvate, 10 mM HEPES
and 0.05 mM 2-mercaptoethanol. All media and supple-
ments were purchased from PAA Laboratories (Pasching,
Austria). A molecular clone of the FIV Petaluma strain was
propagated in FeT-J cells [36]. Parts of the virus genome,
gag and orf-A genes (Genbank: JF411740, JF411742) have
been sequenced for previous studies [37]. Herewith, we
detected 99% sequence homology with the wild-type
Petaluma isolate (Genbank: M25381).
Virus preparation and quantification
Supernatants from FIV-infected FeT-J cells were har-
vested by centrifugation and 0.45 μm filtered. For virusquantification, the amount of FIV RNA in the super-
natant was measured by RT-qPCR. Therefore, viral RNA
was isolated and DNase I digested using the Direct-zol
RNA Miniprep Kit (Zymo Research, Irvine, USA) and
used as a template for RT-qPCR analysis with FIV gag
specific primers and a TaqMan probe [38]. Primer se-
quences can be found in Additional file 2: Table S2. FIV
RNA copy numbers were estimated relative to a tenfold
dilution series of an in-vitro transcribed RNA standard.
PCR reactions conditions and standard generation have
been described earlier [38]. The obtained FIV RNA copy
numbers were then converted into virions/ml super-
natant. Virus preparations were stored at −80°C until
further use for infection experiments.
Infection
A spinoculation protocol was performed in order to in-
crease the numbers of virus particles binding to the tar-
get cells [39]. Briefly, FeT-J cells were resuspended in
FIV-containing supernatant at a MOI of 10 and a cell
density of 1 × 106 cells/ml. Cells were then seeded into
6-well plates and centrifuged at 1200 g for 2 h at 25°C.
Afterwards, the cells were washed three times with cold
medium, transferred into new culture plates and culti-
vated for 8 and 24 h. Control cells were mock-infected
with FIV-free supernatant and treated in the same way.
Four replicate samples were infected for each time point.
The harvested cells were split in half and either frozen
at −20°C for DNA isolation or immediately resuspended
in Trizol reagent (Life Technologies, Carlsbad, USA) for
subsequent RNA isolation.
Quantification of FIV DNA
FIV provirus DNA in infected cells was estimated by
qPCR in order to quantify the infection rates. DNA was
isolated utilizing a commercial kit (DNeasy Blood and
Tissue Kit, Qiagen, Hilden, Germany) according to the
manufacturers’ instructions. qPCR analysis was per-
formed with TaqMan probe assays targeting the FIV
gag [38] and the cat RPP30 gene, 30 kDa subunit of
ribonuclease P (Additional file 2: Table S2). The RPP30
sequence was used for a blast search against the cat
genome, locating one hit on chromosome D2. Thus,
analog to the human genome [40], we assume that
there are two allelic copies RPP30 per cell in the cat
genome and used this qPCR assay for the quantification
of cell numbers (2 copies RPP30 = 1 cell). For the gen-
eration of plasmid DNA standards, parts of the FIV gag
and RPP30 gene were amplified by PCR and cloned into
the pCR2.1 plasmid using the TOPO TA cloning Kit
(Invitrogen, Carlsbad, USA). The prepared plasmid DNA
was used for the generation of standard dilutions ranging
from 1 × 10° – 1 × 106 copies FIV or RPP30. Relating
to both standards, FIV and RPP30 copy numbers were
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conditions for the TaqMan probe qPCR have been de-
scribed earlier [37].
Transcriptome sequencing
Cellular RNA was isolated using the Direct-zol RNA
Miniprep Kit (Zymo Research) including an on-column
DNase I digestion for the removal of gDNA. RNA quality
control was performed by capillary electrophoretic separ-
ation of the samples on the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, USA) and subsequent
estimation of RNA integrity numbers. 1 μg of total RNA
were used as the starting material for the preparation of
cDNA libraries utilizing the TruSeq RNA Sample Prep Kit
v2 (Illumina, San Diego, USA) following the recom-
mended protocol. Sequencing was performed on a
Genome Analyzer IIx instrument (Illumina) with reagents
taken from the TruSeq SR Cluster Kit v5 and TruSeq SBS
Kit v5 (Illumina). The lengths of the generated sequencing
reads were 37 bp. The raw sequencing data are available
in the ArrayExpress database [www.ebi.ac.uk/arrayexpress]
under accession number E-MTAB-2083.
Sequencing data analysis
The Trimmomatic filtering tool was used for quality
control and trimming of the sequencing reads [41]. The
data were scanned for contamination with adapter se-
quences from library preparation. Additionally, all bases
below an Illumina quality score of 25 and reads shorter
than 25 bp were removed. The trimmed data set was
then mapped against the cat genome release 72 from
Ensembl database [ftp://ftp.ensembl.org/pub/release-72/
genbank/felis_catus/] and the FIV Petaluma genome
(Genbank: M25381) using the QSeq v5 analysis software
(DNASTAR, Madison, USA) implementing the default
options for Illumina short reads (matching of a minimum
of 20 bases and at least 80% of bases within each read).
The numbers of raw reads mapping to annotated genes on
the genome reference were counted and fold changes were
calculated by comparing the mean values of four FIV in-
fected samples to four control samples. P-values (Student’s
t-test) were calculated in QSeq v5 and adjusted according
to the Benjamini-Hochberg method [12]. Genes were con-
sidered to be differentially expressed; exhibiting fold
changes > 2, adjusted p-values < 0.05 and RPKM expression
values greater than 0.5 in all replicate samples [11]. For
those genes, which were specified as ‘novel’ or ‘uncharac-
terized’ in the present version of the cat genome, a blast
search in NCBI database was performed and the homolo-
gous human gene symbols were used for further analysis.
RT-qPCR analysis of gene expression
Total RNA was converted into cDNA using the High
Capacity Reverse Transcription Kit (Life Technologies)following the manufacturer’s instructions. Primers were
designed using the Primer Express 3.0 software (Life
Technologies) and validated by the determination of
PCR reaction efficiencies as previously described [42].
All primers are described in Additional file 2: Table S2.
RT-qPCR was performed in 20 μl reactions including
2 μl cDNA template, 200 nM of each primer, 0.2 mM of
each dNTP, 3 mM MgCl2, 1 x Solution S, 1 x buffer B2,
0.4 x EvaGreen fluorescent dye (Biotium, Hayward, USA)
and 1 unit of HOT FIREPol DNA polymerase. All re-
agents for RT-qPCR were purchased from Solis BioDyne
(Tartu, Estonia). Reactions were run on a Viia 7 real-time
PCR instrument (Life Technologies) using the following
temperature protocol: 95°C for 10 min, 45 cycles of 95°C
for 15 sec and 60°C for 1 min, followed by the generation
of melting curves. Target gene expression levels were
normalized to those of three references genes, namely
ABL, B2M and RSP7 [43]. Relative expression changes of
FIV- vs. mock-infected cells were estimated using the
comparative 2^-ΔΔCT method [44].
Data deposition
The RNA-sequencing reads reported in this paper have
been deposited in the ArrayExpress database [www.ebi.
ac.uk/arrayexpress] under accession number E-MTAB-
2083.
Additional files
Additional file 1: Table S1. List of differentially expressed genes in FIV
infected T-cells at 24 hpi as detected by RNA-seq analysis. Fold changes
refer to mock-infected cells. Read counts (log2) represent the mean
values of four replicate samples. P-values were adjusted according to the
Benjamini-Hochberg method.
Additional file 2: Table S2. Primers used for quantitative PCR.
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